Dimaprit, a Histamine H2-Agonist, Inhibits Anaphylactic Histamine Release from Mast Cells and the Decreased Release Is Restored by Thioperamide (H3-Antagonist), but Not by Cimetidine (H2-Antagonist)

The Japanese Journal of Pharmacology

Takeshi Nabe¹  Kohji Ogawa¹  Shigekatsu Kohno¹  Hideki Yamamura¹  Katsuya Ohata¹ 

[1] Department of Pharmacology, Kyoto Pharmaceutical University

关键词: Mast cell;    Histamine;    Dimaprit;    Thioperamide;    (R)-α-Methylhistamine;   

DOI  :  10.1254/jjp.62.75

学科分类：药理学

来源: Nihon Yakuri Gakkai Henshuubu / Japanese Pharmacological Society

【 摘 要 】

References(19)Cited-By(8)Whether anaphylactic histamine release from rat peritoneal mast cells is influenced by betahistine, a histamine H1-receptor agonist/H3-antagonist, and dimaprit, an H2-agonist, was examined. Treatment with dimaprit at 6 and 60 μM for 20 min significantly inhibited the anaphylactic histamine release, whereas betahistine at up to 80 μM under the same conditions did not affect it. Treatment with dimaprit at 6 and 60 μM for 1 to 20 min and for 5 to 20 min, respectively, caused a time-dependent inhibition of the release, but up to 30 min treatment with 8 and 80 μM betahistine had no effect. The decreased histamine release induced by dimaprit was recovered by neither mepyramine nor cimetidine. However, thioperamide, an H3-selective antagonist, dose-dependently restored the diminished release. From these results, the inhibition of anaphylactic histamine release by dimaprit is not produced by the stimulation of H2-receptors, but involves the stimulation of H3-like receptors or H3-subtype receptors, which are distinct from the H3-receptors located in brain, and suggests that the receptor plays an important role in the negative feedback regulation of histamine release.

【 授权许可】

Unknown